Healthy.io Secures $18 Million in Series B Funding to Bring Novel Urine Analysis Technology to the U.S.

VCBeat (WeChat ID: vcbeat) has learned that Healthy.io, an innovative Israeli healthcare company, recently announced it had raised $18 million in its Series B financing round. The round was led by the Israeli venture capital firm Aleph, with participation from Samsung Next and several individual investors. The funds will be used to expand its operations in the United States.

Healthy.io, founded in 2013, primarily focuses on transforming everyday smartphones into clinical-grade medical devices. The company’s core product is Dip.io, a home urine testing kit that includes a urine collection cup, test strips, and a color comparison card.

Traditionally, patients seeking urine testing must visit a hospital for complex procedures, which is highly time-consuming. The advent of Dip.io enables users to perform accurate, clinical-grade urine analysis at home in just a few minutes. All that is required is a smartphone and the Healthy.io test kit. To conduct the test, the user collects urine in a cup, dips the test strip into the sample, and places it in the slot of a color comparison card. After 60 seconds, the user takes a photo with their smartphone and uploads it to the app, which automatically generates the test results. The test records are compiled into an electronic medical record document and sent to either the patient or their private physician.

Healthy.io has stated that Dip.io has obtained CE marking and ISO 13485 certification, qualifying it for sale in EU countries; it has also received FDA 510(k) Class II clearance, qualifying it for sale in the United States. To date, Dip.io has been used by 100,000 patients.

“Chronic kidney disease is a fatal and costly-to-treat condition. According to our research, approximately 10% of the global population suffers from kidney disease. In the United States, annual spending on kidney disease treatment amounts to roughly $114 billion,” said Yonatan Adiri, CEO and Founder of Healthy.io. “This round of financing will provide ample capital support for our entry into the U.S. market, and we are optimistic about Healthy.io’s growth prospects in the United States.”

Aleph, established in 2013, is an Israeli venture capital firm that has primarily focused on investing in startups and high-tech companies in recent years.

(Compiled by Hu Xuan)